---
title: "TBPH.US (TBPH.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TBPH.US/news.md"
symbol: "TBPH.US"
name: "TBPH.US"
parent: "https://longbridge.com/en/quote/TBPH.US.md"
datetime: "2026-05-22T01:32:44.885Z"
locales:
  - [en](https://longbridge.com/en/quote/TBPH.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TBPH.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TBPH.US/news.md)
---

# TBPH.US (TBPH.US) — Related News

### [Theravance: Hold Rating Reiterated as Restructuring Progress and Cash Flow Visibility Support Unchanged $15 Price Target](https://longbridge.com/en/news/285663187.md)
*2026-05-08T04:05:59.000Z*
> TD Cowen analyst Marc Frahm reiterated a Hold rating on Theravance Biopharma with a price target of $15.00, citing a sol

### [Theravance BioPharma | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 17.7 M](https://longbridge.com/en/news/285553665.md)
*2026-05-07T12:40:13.000Z*
### [Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update | TBPH Stock News](https://longbridge.com/en/news/285551659.md)
*2026-05-07T04:30:34.000Z*
> Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update | TBPH Stock News

### [Theravance Biopharma Reaches Analyst Target Price](https://longbridge.com/en/news/285195771.md)
*2026-05-05T11:20:14.000Z*
> Theravance Biopharma, Inc. (TBPH) shares have surpassed the average analyst 12-month target price of $16.83, trading at 

### [Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Rating of "Moderate Buy" by Brokerages](https://longbridge.com/en/news/284079838.md)
*2026-04-25T10:51:27.000Z*
> Theravance Biopharma, Inc. (NASDAQ:TBPH) has received a consensus rating of "Moderate Buy" from eight research firms. An

### [Bora Biologics Successfully Completes 2,000L Engineering and Scale-Up Run in San Diego, Reinforcing Commercial-Scale Readiness](https://longbridge.com/en/news/281757479.md)
*2026-04-06T12:05:28.000Z*
> Bora Biologics has successfully completed its first 2,000-liter engineering and scale-up run at its FDA-approved facilit

### [Why did OpenAI acquire the tech talk show TBPN? Foreign media analysis reveals the reasons](https://longbridge.com/en/news/281604228.md)
*2026-04-03T04:40:02.000Z*
> OpenAI recently acquired the technology talk show TBPN, attracting market attention. Although TBPN has a small audience,

### [TBPH Investors Have Opportunity to Join Theravance Biopharma, Inc. Fraud Investigation with the Schall Law Firm](https://longbridge.com/en/news/281589536.md)
*2026-04-03T00:55:25.000Z*
> The Schall Law Firm is investigating claims on behalf of investors of Theravance Biopharma, Inc. (NASDAQ: TBPH) for pote

### [Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Average Rating of "Moderate Buy" from Analysts](https://longbridge.com/en/news/281172073.md)
*2026-03-31T10:45:49.000Z*
> Theravance Biopharma, Inc. (NASDAQ:TBPH) has received a consensus recommendation of "Moderate Buy" from eight analysts.